01 1Olon S.p.A.
02 1Professional Compounding Centers of America dba PCCA
03 4Zhejiang Kingland Pharmaceutical Company Limited
01 1Alpha Lipoic Acid
02 3Alpha Lipoic acid
03 2Alpha-Lipoic Acid
01 4China
02 1Italy
03 1United Kingdom
NDC Package Code : 84824-002
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84824-002
Start Marketing Date : 2024-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84824-002
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84824-002
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0402
Start Marketing Date : 2017-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-5064
Start Marketing Date : 2019-07-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
80
PharmaCompass offers a list of Alpha Lipoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alpha Lipoic Acid manufacturer or Alpha Lipoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alpha Lipoic Acid manufacturer or Alpha Lipoic Acid supplier.
PharmaCompass also assists you with knowing the Alpha Lipoic Acid API Price utilized in the formulation of products. Alpha Lipoic Acid API Price is not always fixed or binding as the Alpha Lipoic Acid Price is obtained through a variety of data sources. The Alpha Lipoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alpha Liponsaure Sofotec manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpha Liponsaure Sofotec, including repackagers and relabelers. The FDA regulates Alpha Liponsaure Sofotec manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpha Liponsaure Sofotec API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alpha Liponsaure Sofotec manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alpha Liponsaure Sofotec supplier is an individual or a company that provides Alpha Liponsaure Sofotec active pharmaceutical ingredient (API) or Alpha Liponsaure Sofotec finished formulations upon request. The Alpha Liponsaure Sofotec suppliers may include Alpha Liponsaure Sofotec API manufacturers, exporters, distributors and traders.
click here to find a list of Alpha Liponsaure Sofotec suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alpha Liponsaure Sofotec as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alpha Liponsaure Sofotec API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alpha Liponsaure Sofotec as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alpha Liponsaure Sofotec and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alpha Liponsaure Sofotec NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alpha Liponsaure Sofotec suppliers with NDC on PharmaCompass.
We have 3 companies offering Alpha Liponsaure Sofotec
Get in contact with the supplier of your choice:
